Print（PDF/252KB） Dec. 22, 2025 Others

Sumitomo Pharma Selected as “Best Website” for the Third Consecutive Year in Both All Markets and Pharmaceuticals Sector Categories of Nikko Investor Relations’ FY2025 All-Listed-Companies Website Ranking

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Toru Kimura) today announced that its corporate website (https://www.sumitomo-pharma.com) has been selected as the highest-ranked “Best Website” in both the All Markets and the Pharmaceuticals Sector of the FY2025 All-Listed-Companies Website Ranking, conducted by Nikko Investor Relations Co., Ltd. (“Nikko IR”), for the third consecutive year.

The FY2025 All-Listed-Companies Website Ranking is conducted by Nikko IR to assess the level of information disclosure on websites of all listed companies in Japan and to promote greater awareness of corporate disclosure. A total of 3,937 corporate websites were evaluated based on 168 objective assessment items across three key perspectives: clarity, usability, and information volume.

Sumitomo Pharma will continue to further enhance site usability, enrich content, and proactively communicate information to ensure its corporate website remains a clear, easy-to-use, and valuable resource for all stakeholders.

For details on Nikko IR’s FY2025 All-Listed-Companies Website Ranking, please refer to the following (in Japanese only):
https://www.nikkoir.co.jp/rank/pdf/nkir_result_2025.pdf